| Literature DB >> 29164375 |
Annette J van Nieuwenhuizen1, Laurien M Buffart2,3, Cornelia F van Uden-Kraan1,4, Lilly-Ann van der Velden5,6, Martin Lacko7, Johannes Brug2, C René Leemans1, Irma M Verdonck-de Leeuw8,9.
Abstract
PURPOSE: This study aimed to assess patient-reported levels of physical activity (PA) and its associations with health-related quality of life (HRQoL) adjusted for important demographic, lifestyle-related, and clinical factors, among head and neck (HNC) survivors.Entities:
Keywords: Exercise; Head and neck neoplasm; Health-related quality of life; Physical activity; Physical functioning
Mesh:
Year: 2017 PMID: 29164375 PMCID: PMC5847044 DOI: 10.1007/s00520-017-3926-y
Source DB: PubMed Journal: Support Care Cancer ISSN: 0941-4355 Impact factor: 3.603
Fig. 1Inclusion flowchart
Demographic, lifestyle-related, and clinical characteristics, physical activity (PA), and health-related quality of life (HRQoL)
| Characteristics | Participants ( |
|---|---|
|
| |
| Gender, | 73 (63) |
| Age, mean (SD) years | 60 (10) |
| SES, mean (SD) | 0.5 (0.9) |
| High SES (above average), | 34 (29) |
|
| |
| Smoking (pack years), median (IQR) | 20 (0–40) |
| Smoking at diagnosis, n (%) | 63 (54) |
| Alcohol use (units per day), mean (SD) | 1.5 (2.3) |
| Alcohol abusea at diagnosis, n (%) | 23 (20) |
|
| |
| Tumor location, | |
| Oral cavity and oropharynx | 56 (48) |
| Larynx and hypopharynx | 33 (29) |
| Otherb | 27 (23) |
| Cancer type, | |
| Squamous cell | 105 (91) |
| Non-squamous cell | 11 (9) |
| Disease Stage, | |
| I and II | 41 (35) |
| III and IV | 75 (65) |
| Type of treatment, | |
| Surgery only | 21 (18) |
| Radiotherapy | 28 (24) |
| Chemoradiotherapy | 23 (20) |
| Surgery combined with (chemo)radiation therapy | 44 (38) |
| Recurrence, | |
| None | 95 (82) |
| Any | 21 (18) |
| Comorbidity, | |
| None or mild | 74 (64) |
| Moderate or severe | 42 (36) |
| Time since treatment, mediam (IQR) months | 14 (7–23) |
|
| |
| Total score, median (IQR) | 100.3 (65.1–170.8) |
| Leisure-time activities (% of total PA) | 34% |
| Household activities | 54% |
| Occupational activities | 12% |
|
| |
| Global quality of life | 78.2 (15.9) |
| Physical function | 88.0 (13.7) |
| Role function | 85.5 (19.6) |
| Emotional function | 85.9 (14.0) |
| Cognitive function | 89.7 (14.9) |
| Social function | 85.6 (19.0) |
| Fatigue | 23.9 (21.5) |
| Pain (general) | 14.2 (19.9) |
| Dyspnea | 14.4 (22.9) |
| Insomnia | 16.1 (35.4) |
| Loss of appetite | 6.0 (17.9) |
| Constipation | 9.2 (20.9) |
| Diarrhea | 5.2 (13.6) |
| Financial problems | 9.8 (21.1) |
| Tumor specific HRQoL, mean (SD | |
| Pain (mouth) | 17.0 (20.9) |
| Swallowing | 16.7 (23.4) |
| Senses | 21.3 (23.4) |
| Speech problems | 16.4 (20.5) |
| Social eating | 15.1 (22.5) |
| Social contact | 5.1 (8.9) |
| Sexuality | 24.5 (29.7) |
| Teeth | 13.9 (24.2) |
| Opening mouth | 13.5 (22.4) |
| Dry mouth | 42.8 (31.3) |
| Sticky saliva | 30.4 (32.3) |
| Coughing | 20.7 (27.3) |
| Feel ill | 9.8 (19.7) |
CRT chemoradiation, n number, RT radiotherapy, SD standard deviation, SES socio-economic status, Surg surgery
aAlcohol abuse defined as ≥ 5 units of alcohol per day
bUnknown primary, nasopharynx, nasal cavity, nasal sinus, salivary glands, ear, and skin
Demographic, lifestyle-related and clinical correlates of physical activity. Results from univariable regression analyses
| Ratio (95% CI) |
| Standardized regression coefficients | |
|---|---|---|---|
|
| |||
| Gender | 1.28 (0.93; 1.77) | 0.13 | 0.14 |
| Age, years | 0.98 (0.96; 1.00) | 0.01 | −0.23 |
| SES | 0.95 (0.68; 1.34) | 0.78 | −0.03 |
|
| |||
| Smoking, pack years | 1.00 (1.00; 1.01) | 0.32 | 0.09 |
| Smoking at diagnosis | 1.20 (0.88; 1.64) | 0.25 | 0.11 |
| Alcohol, units per day | 0.99 (1.07; 1.06) | 0.79 | 0.02 |
| Alcohol abusea | 0.92 (0.62; 1.36) | 0.67 | −0.04 |
|
| |||
| Tumor location | |||
| OC and OP | 1.33 (0.89; 1.98) | 0.16 | 0.17 |
| L and HP | 1.22 (0.78; 1.89) | 0.38 | 0.10 |
| Other | Ref | ||
| Cancer type | 1.51 (0.88; 2.57) | 0.13 | 0.14 |
| Disease Stage | 0.98 (0.70; 1.36) | 0.89 | −0.01 |
| Recurrence | 0.69 (0.46; 1.04) | 0.07 | −0.17 |
| Comorbidity | 0.82 (0.59; 1.14) | 0.23 | −0.11 |
| Type of treatment | |||
| Single vs. multiple | 0.92 (0.67; 1.27) | 0.62 | −0.05 |
| Time since treatment (months) | 0.99 (0.99; 1.00) | 0.10 | −0.15 |
CI confidence interval, L and HP larynx and hypopharynx, OC and OP oral cavity and oropharynx, Ref reference SES socio-economic status
aAlcohol abuse defined as ≥ 5 units of alcohol per day
Gender (0 = male, 1 = female), SES (0 = other, 1 = high), current smoking (0 = never or former, 1 = current), alcohol abuse (0 = no abuse, 1 = current or former abuse), cancer type (0 = no squamous cell carcinoma, 1 = squamous cell carcinoma), disease stage (0 = stage I and II, 1 = stage III and IV), recurrence (0 = no recurrence, 1 = any recurrence), comorbidity (0 = none or mild, 1 = moderate or severe)
Independent correlates of physical activity. Results of the multivariable regression analyses
| Ratio (95% CI) |
| Standardized regression coefficients | |
|---|---|---|---|
|
| |||
| Age, years | 0.98 (0.96; 1.00) | 0.01 | −0.23 |
Variables were selected one by one and all variables with p ≤ 0.05 were inserted in the multiple regression model
The association between physical activity and health-related quality of life (HRQoL)
| Univariable analyses |
| Multivariable analysesa |
| |
|---|---|---|---|---|
| HRQoL | β (95% CI) | β (95% CI) | ||
| Global quality of life | 0.059 (0.025; 0.092) | 0.01 | 0.061 (0.025; 0.096) | 0.00 |
| Physical function | 0.034 (0.004; 0.063) | 0.03 | 0.027 (−0.003; 0.057) | 0.08 |
| Role functioning | 0.040 (−0.003; 0.082) | 0.07 | 0.044 (−0.001; 0.089) | 0.05 |
| Emotional functioning | 0.011 (−0.020; 0.042) | 0.49 | 0.004 (−0.030; 0.038) | 0.81 |
| Social functioning | 0.034 (−0.008; 0.075) | 0.11 | 0.043 (−0.002; 0.088) | 0.06 |
| Cognitive functioning | 0.019 (−0.013; 0.052) | 0.24 | 0.018 (−0.019; 0.055) | 0.33 |
| Fatigue | −0.043 (−0.090; 0.04) | 0.07 | −0.050 (−0.103; 0.003) | 0.06 |
| Nausea and vomiting | 0.000 (−0.017; 0.017) | 0.97 | −0.004 (−0.024; 0.015) | 0.65 |
| Pain (general) | −0.050 (−0.092; -0.007) | 0.02 | −0.044 (−0.091; 0.003) | 0.06 |
| Dyspnoe | 0.013 (−0.038; 0.063) | 0.62 | 0.050 (−0.046; 0.056) | 0.84 |
| Insomnia | −0.027 (−0.083; 0.029) | 0.34 | −0.044 (−1.05; 0.017) | 0.15 |
| Loss of appetite | 0.012 (−0.027; 0.052) | 0.54 | 0.001 (−0.042; 0.045) | 0.96 |
| Constipation | −0.026 (−0.072; 0.020) | 0.27 | −0.021 (−0.072; 0.030) | 0.42 |
| Diarrhea | −0.017 (−0.046; 0.013) | 0.27 | −0.019 (−0.053; 0.015) | 0.28 |
| Financial problems | 0.09 (−0.037; 0.056) | 0.67 | 0.016 (−0.036; 0.068) | 0.54 |
| Tumor specific HRQoL | ||||
| Pain (mouth) | −0.015 (−0.061; 0.031) | 0.53 | −0.009 (−0.060; 0.043) | 0.74 |
| Swallowing | −0.022 (−0.074; 0.029) | 0.39 | −0.022 (−0.073; 0.029) | 0.39 |
| Senses | −0.028 (−0.079; 0.024) | 0.29 | −0.019 (−0.076; 0.038) | 0.51 |
| Speech problems | −0.005 (−0.050; 0.040) | 0.83 | 0.004 (−0.045; 0.054) | 0.86 |
| Social eating | −0.022 (−0.071; 0.027) | 0.38 | −0.021 (−0.071; 0.030) | 0.42 |
| Social contact | −0.008 (−0.028; 0.012) | 0.43 | −0.005 (−0.026; 0.017) | 0.68 |
| Sexuality | −0.037 (−0.105; 0.031) | 0.29 | −0.048 (−0.118; 0.022) | 0.18 |
| Teeth | 0.028 (−0.025; 0.081) | 0.30 | 0.019 (−0.039; 0.077) | 0.51 |
| Opening mouth | −0.031 (−0.080; 0.018) | 0.21 | −0.031 (−0.084; 0.023) | 0.26 |
| Dry mouth | 0.009 (−0.060; 0.078) | 0.80 | 0.001 (−0.073; 0.075) | 0.99 |
| Sticky saliva | 0.005 (−0.066; 0.077) | 0.88 | 0.007 (−0.069; 0.083) | 0.86 |
| Coughing | −0.028 (−0.088; 0.032) | 0.36 | −0.026 (−0.090; 0.038) | 0.42 |
| Feeling ill | −0.018 (−0.061; 0.026) | 0.42 | −0.032 (−0.082; 0.016) | 0.30 |
aAdjusted for age, gender, socio-economic status, smoking, alcohol abuse, comorbidity, tumor stage, treatment, recurrence, and time since treatment